- Yesterday, Janet Woodcock, M.D., the Principle Deputy Commissioner for the Office of the FDA Commissioner, released a statement regarding the Agency’s approach towards cannabidiol (CBD) and its application in the
DIETARY SUPPLEMENTS
FDA Letter States that β-Nicotinamide Mononucleotide is Not Lawful Dietary Supplement
Posted on
- This past summer Inner Mongolia Kingdomway Pharmaceutical Limited (“Kingdom”) submitted a new dietary ingredient (NDI) notification to FDA for β-Nicotinamide Mononucleotide (NMN), a compound that has been touted for its
FDA Issues Warning Letters to 7 Dietary Supplement Companies for Drug Claims
Posted on
- On November 17, 2022, FDA posted warning letters to 7 companies for selling different dietary supplements with claims that caused the products to be “drugs” in violation of the Federal
…
Continue Reading FDA Issues Warning Letters to 7 Dietary Supplement Companies for Drug Claims
FDA Finalizes NAC Enforcement Discretion Guidance
Posted on
- FDA issued final guidance regarding its decision to exercise enforcement discretion with respect to the sale and distribution of dietary supplements containing N-acetyl-L-cysteine (NAC). The final guidance is substantively identical
…
Continue Reading FDA Finalizes NAC Enforcement Discretion Guidance
Georgia Court Finds Dietary Supplement Labeling Claim within FDA’s Jurisdiction
Posted on
- On June 24, the Court of Appeals of Georgia held that Plaintiff Shawn Smith’s deceptive product labeling case raised questions best left to the FDA.
- By way of background, in
…
Continue Reading Georgia Court Finds Dietary Supplement Labeling Claim within FDA’s Jurisdiction
Senate Committee Passes the FDA Safety and Landmark Advancements Act
Posted on
- On June 14, 2022, the Senate Health, Education, Labor, and Pensions (HELP) Committee passed the FDA Safety and Landmark Advancements (FDASLA) Act (S. 4348) which proposes various changes
…
Continue Reading Senate Committee Passes the FDA Safety and Landmark Advancements Act
FDA Releases Draft Guidance on NAC Enforcement
Posted on
- On April 21, 2022 FDA announced the issuance of draft guidance on FDA’s policy regarding dietary supplements containing N-acetyl cysteine (NAC). The guidance details the agency’s intent to exercise enforcement
…
Continue Reading FDA Releases Draft Guidance on NAC Enforcement
Challenge to Dietary Supplement Structure/Function Claims Preempted
Posted on
- On March 31, 2022, the U.S. District Court for the District of Massachusetts held that Plaintiffs’ claims— which alleged that the labels on three of Vitamin Shoppe, Inc.’s dietary supplements
…
Continue Reading Challenge to Dietary Supplement Structure/Function Claims Preempted
Permanent Injunction against Supplement Co.
Posted on
- On March 3, 2022, the United States Government, on behalf of FDA, filed a complaint against Salud Natural Entrepreneur, Inc. (“Salud”), as well as its owner, production manager, and quality
…
Continue Reading Permanent Injunction against Supplement Co.
FDA & FTC Issue Warning Letters to 10 Companies
Posted on
- On September 9, 2021, the Food and Drug Administration (FDA) and Federal Trade Commission (FTC) jointly issued warning letters to 10 companies for illegally selling dietary supplements claiming to treat
…
Continue Reading FDA & FTC Issue Warning Letters to 10 Companies